Literature DB >> 31236716

Updates on Management of Gastric Cancer.

Fabian M Johnston1, Michael Beckman2.   

Abstract

PURPOSE OF REVIEW: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection. RECENT
FINDINGS: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.

Entities:  

Keywords:  CYTO-CHIP; FLOT; Gastric adenocarcinoma; Gastric cancer; HIPEC; Siewert type III

Year:  2019        PMID: 31236716     DOI: 10.1007/s11912-019-0820-4

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  49 in total

1.  Robot-assisted gastric surgery.

Authors:  Makoto Hashizume; Keizo Sugimachi
Journal:  Surg Clin North Am       Date:  2003-12       Impact factor: 2.741

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 3.  Staging and follow-up of gastrointestinal tumors with PET/CT.

Authors:  S J Rosenbaum; H Stergar; G Antoch; P Veit; A Bockisch; H Kühl
Journal:  Abdom Imaging       Date:  2006 Jan-Feb

4.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

Review 5.  Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review.

Authors:  Srinivas-R Puli; Jyotsna-Bk Reddy; Matthew-L Bechtold; Daphne Antillon; Jamal-A Ibdah; Mainor-R Antillon
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 6.  Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract.

Authors:  Roy Soetikno; Tonya Kaltenbach; Ronald Yeh; Takuji Gotoda
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

7.  Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial.

Authors:  Cristiano G S Huscher; Andrea Mingoli; Giovanna Sgarzini; Andrea Sansonetti; Massimiliano Di Paola; Achille Recher; Cecilia Ponzano
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

8.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

9.  Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.

Authors:  Jason J Hall; Brian W Loggie; Perry Shen; Staci Beamer; L Douglas Case; Richard McQuellon; Kim R Geisinger; Edward A Levine
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

10.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

View more
  101 in total

1.  Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway.

Authors:  Qian Xie; Jing Wang; Wenwen Wu; Ye Zhao
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

2.  Hsa_circular RNA_0001013 exerts oncogenic effects in gastric cancer through the microRNA-136-TWSG1 axis.

Authors:  Zhaofeng Gao; Lingyu Hu; Fei Chen; Chunhua He; Biwen Hu; Xiaoguang Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 3.  The role of LncRNA LBX2-AS1 in cancers: functions, mechanisms and potential clinical utility.

Authors:  Yuanshuai Su; Chengzhi Li; Yu Fang; Xinyu Gu; Qiuxian Zheng; Juan Lu; Lanjuan Li
Journal:  Clin Transl Oncol       Date:  2022-09-21       Impact factor: 3.340

4.  LncRNA SNHG6 inhibits autophagy of gastric carcinoma cells via PI3K/AKT/mTOR signaling pathway.

Authors:  Wenliang Chen; Zhuo Li; Junfang Duan; Yingtao Liu; Changzhong Fang; Zihao Bai
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

5.  The lncRNA ZNF667-AS1 Inhibits Propagation, Invasion, and Angiogenesis of Gastric Cancer by Silencing the Expression of N-Cadherin and VEGFA.

Authors:  Chong Yu; Wenqian Chen; Yi Cai; Mingyu Du; Dan Zong; Luxi Qian; Xuesong Jiang; Huanfeng Zhu
Journal:  J Oncol       Date:  2022-07-01       Impact factor: 4.501

6.  Silencing of immunoglobulin superfamily containing leucine-rich repeat inhibits gastric cancer cell growth and metastasis by regulating epithelial-mesenchymal transition.

Authors:  Aitao Sun; JinBo Li; Weijing Kong; Xiaodong Jiang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 7.  Ferroptosis: mechanisms, biology and role in disease.

Authors:  Xuejun Jiang; Brent R Stockwell; Marcus Conrad
Journal:  Nat Rev Mol Cell Biol       Date:  2021-01-25       Impact factor: 94.444

Review 8.  Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies.

Authors:  Tahereh Farkhondeh; Ali Mohammad Pourbagher-Shahri; Mohsen Azimi-Nezhad; Fatemeh Forouzanfar; Aranka Brockmueller; Milad Ashrafizadeh; Marjan Talebi; Mehdi Shakibaei; Saeed Samarghandian
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

9.  Identification of Early Diagnostic and Prognostic Biomarkers via WGCNA in Stomach Adenocarcinoma.

Authors:  Ruoyue Tan; Guanghui Zhang; Ruochen Liu; Jianbing Hou; Zhen Dong; Chaowei Deng; Sicheng Wan; Xiaodong Lai; Hongjuan Cui
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

10.  The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer.

Authors:  Kei Nakamura; Atsushi Shiozaki; Toshiyuki Kosuga; Hiroki Shimizu; Michihiro Kudou; Takuma Ohashi; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Eigo Otsuji
Journal:  Gastric Cancer       Date:  2021-07-12       Impact factor: 7.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.